Bank Of New York Mellon Corp Arrowhead Pharmaceuticals, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$23.68 - $38.51 $24.6 Million - $40.1 Million	1,039,993 New	1,039,993 $26.4 Billion
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $29.9 Million - $43.3 Million	1,067,109 New	1,067,109 $43.3 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $1.1 Million - $1.8 Million	37,243 Added 3.59%	1,073,815 $35.5 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $226,988 - $413,382	-8,168 Reduced 0.78%	1,036,572 $36.5 Million
Q1 2022 May 11, 2022	BUY	$39.62 - $69.97 $39,184 - $69,200	989 Added 0.09%	1,044,740 $48 Million
Q4 2021 Feb 11, 2022	SELL	$58.09 - $82.51 $910,967 - $1.29 Million	-15,682 Reduced 1.48%	1,043,751 $69.2 Million
Q3 2021 Nov 12, 2021	SELL	$58.38 - $84.96 $1.52 Million - $2.21 Million	-26,038 Reduced 2.4%	1,059,433 $66.1 Million
Q2 2021 Aug 11, 2021	BUY	$62.15 - $90.32 $4.34 Million - $6.31 Million	69,835 Added 6.88%	1,085,471 $89.9 Million
Q1 2021 May 13, 2021	SELL	$61.35 - $90.47 $1.32 Million - $1.94 Million	-21,435 Reduced 2.07%	1,015,636 $67.3 Million
Q4 2020 Feb 09, 2021	SELL	$43.82 - $85.37 $1.03 Million - $2.01 Million	-23,600 Reduced 2.23%	1,037,071 $79.6 Million
Q3 2020 Nov 12, 2020	SELL	$33.21 - $51.27 $1.18 Million - $1.83 Million	-35,626 Reduced 3.25%	1,060,671 $45.7 Million
Q2 2020 Aug 12, 2020	BUY	$26.12 - $43.27 $801,857 - $1.33 Million	30,699 Added 2.88%	1,096,297 $47.3 Million
Q1 2020 May 06, 2020	BUY	$20.56 - $63.12 $57,506 - $176,546	2,797 Added 0.26%	1,065,598 $30.7 Million
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $972,462 - $2.52 Million	-34,558 Reduced 3.15%	1,062,801 $67.4 Million
Q3 2019 Nov 07, 2019	BUY	$26.26 - $34.86 $879,788 - $1.17 Million	33,503 Added 3.15%	1,097,359 $30.9 Million
Q2 2019 Aug 12, 2019	BUY	$17.43 - $28.82 $12 Million - $19.9 Million	689,592 Added 184.25%	1,063,856 $28.2 Million
Q1 2019 May 14, 2019	BUY	$12.05 - $20.18 $196,945 - $329,821	16,344 Added 4.57%	374,264 $6.87 Million
Q4 2018 Feb 11, 2019	SELL	$10.74 - $19.7 $771,776 - $1.42 Million	-71,860 Reduced 16.72%	357,920 $4.45 Million
Q3 2018 Nov 09, 2018	BUY	$14.0 - $20.3 $1.25 Million - $1.82 Million	89,536 Added 26.32%	429,780 $0
Q2 2018 Aug 06, 2018	BUY	$6.37 - $14.02 $1.68 Million - $3.69 Million	263,205 Added 341.65%	340,244 $4.63 Million
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $64,635 - $132,745	17,375 Added 29.12%	77,039 $555,000
Q4 2017 Feb 09, 2018	BUY	$3.14 - $4.5 $187,344 - $268,488	59,664	59,664 $220,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account